DA

David Amantini

GN Galapagos Nv: 9 patents #22 of 177Top 15%
GL Glaxo Group Limited: 4 patents #243 of 1,368Top 20%
LS Les Laboratoires Servier: 3 patents #121 of 516Top 25%
CL Convergence Pharmaceuticals Limited: 1 patents #22 of 38Top 60%
📍 Romainville, FR: #9 of 68 inventorsTop 15%
Overall (All Time): #332,551 of 4,157,543Top 8%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
12264156 Compounds and pharmaceutical compositions thereof for the treatment of diseases Reginald Christophe Xavier Brys, Denis BUCHER, Steve Irma Joel De Vos, Nicolas Desroy, Agnès Marie JONCOUR +3 more 2025-04-01
11718588 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, Frédéric André De Ceuninck, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2023-08-08
11564923 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Steven Emiel Van der Plas, Oscar Mammoliti, Sébastien Laurent Xavier Martina, Pieter Isabelle Roger Claes, Ghjuvanni Petru Diunisu Coti +4 more 2023-01-31
11136325 Pyrrolopyrimidine and pyrrolopyridine derivatives Milan Mesic, Gordon Saxty, Tanja Poljak, Ines VUJASINOVIC, Dinko ZIHER +2 more 2021-10-05
10941117 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, Frédéric André De Ceuninck, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2021-03-09
10829478 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis Frédéric Gilbert LABÉGUÈRE, Rama Heng, Frédéric André De Ceuninck, Luke Jonathan Alvey, Franck Laurent Brebion +6 more 2020-11-10
10550100 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis Frédéric Gilbert LABÉGUÈRE, Rama Heng, Frédéric André De Ceuninck, Luke Jonathan Alvey, Franck Laurent Brebion +6 more 2020-02-04
10487060 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, Frédéric André De Ceuninck, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2019-11-26
9926281 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Franck Laurent Brebion, Luke Jonathan Alvey, Frédéric André De Ceuninck, Pierre Deprez, Romain Luc Marie Gosmini +4 more 2018-03-27
8153623 Compounds Giuseppe Alvaro, Markus Bergauer, Francesca Bonetti, Roberto Profeta 2012-04-10
8133908 Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amine Giuseppe Alvaro, Emiliano Castiglioni, Romano Di Fabio, Francesca Pavone 2012-03-13
8129384 Imidazo[1,2-a]pyrazines as orexin receptor antagonists Giuseppe Alvaro, Sandro Belvedere 2012-03-06
8093255 Imidazo[1,2-A]pyrimidines as orexin receptor antagonists Giuseppe Alvaro, Sandro Belvedere 2012-01-10
7803833 Compounds Giuseppe Alvaro, Markus Bergauer, Francesca Bonetti, Roberto Profeta 2010-09-28